{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:56:17Z","timestamp":1787313377377,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001878"],"award-info":[{"award-number":["UL1TR001878"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK056268"],"award-info":[{"award-number":["R01DK056268"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK063688"],"award-info":[{"award-number":["T32DK063688"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS116504"],"award-info":[{"award-number":["R01NS116504"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS087516"],"award-info":[{"award-number":["R01NS087516"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["T32NS091006"],"award-info":[{"award-number":["T32NS091006"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["P41EB029460"],"award-info":[{"award-number":["P41EB029460"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["P41EB015893"],"award-info":[{"award-number":["P41EB015893"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH119185"],"award-info":[{"award-number":["R01MH119185"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R56AG066656"],"award-info":[{"award-number":["R56AG066656"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Pennsylvania Protocol Development Award"},{"name":"Children\u2019s Hospital of Philadelphia Advancement of Hyperinsulinism Care and Research Frontier Program"},{"DOI":"10.13039\/100013845","name":"Pediatric Endocrine Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013845","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Hyperinsulinism hyperammonemia (HI\/HA) syndrome is caused by activating mutations in\n                      <jats:italic>GLUD1<\/jats:italic>\n                      , encoding glutamate dehydrogenase (GDH). Atypical absence seizures and neuropsychological disorders occur at high rates in this form of hyperinsulinism. Dysregulated central nervous system (CNS) glutamate balance, due to GDH overactivity in the brain, has been hypothesized to play a role. This study aimed to describe the neurologic phenotype in HI\/HA syndrome and investigate CNS glutamate levels using glutamate weighted chemical exchange saturation transfer magnetic resonance imaging (GluCEST MRI). In this cross-sectional study, 12 subjects with HI\/HA syndrome had plasma ammonia measurement, self- or parent-completed neurocognitive assessments, electroencephalogram (EEG), and GluCEST MRI at 7 T performed. GluCEST MRI measures were compared to a historic reference population of 10 healthy adults.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Subjects were five males and seven females with median age of 25.5\u00a0years. Seventy-five percent of subjects reported a history of neurodevelopmental problems and 42% had neurocognitive assessment scores outside the normal range. Fifty percent had interictal EEG findings of generalized, irregular spike and wave discharges. Higher variability in hippocampal GluCEST asymmetry (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), and in peak hippocampal GluCEST values (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008), was observed in HI\/HA subjects (n\u2009=\u20099 with interpretable MRI) compared to the healthy reference population (n\u2009=\u200910).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The high prevalence of abnormal neurocognitive assessment scores and interictal EEG findings observed highlights the importance of longitudinal neuropsychological assessment for individuals with HI\/HA syndrome. Our findings demonstrate the potential application of GluCEST to investigate persistent knowledge gaps in the mechanisms underlying the unique neurophenotype of this disorder.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-022-02398-3","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T09:03:46Z","timestamp":1656147826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Characterizing the neurological phenotype of the hyperinsulinism hyperammonemia syndrome"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1959-4457","authenticated-orcid":false,"given":"Elizabeth","family":"Rosenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Prakash Reddy","family":"Nanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Y.","family":"Revell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina H.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Roalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell T.","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1225-8087","authenticated-orcid":false,"given":"Diva D.","family":"De Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,25]]},"reference":[{"issue":"2","key":"2398_CR1","doi-asserted-by":"publisher","first-page":"E355","DOI":"10.1210\/jc.2012-2169","volume":"98","author":"KE Snider","year":"2013","unstructured":"Snider KE, Becker S, Boyajian L, Shyng SL, MacMullen C, Hughes N, et al. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab. 2013;98(2):E355\u201363.","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"2398_CR2","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1056\/NEJM199805073381904","volume":"338","author":"CA Stanley","year":"1998","unstructured":"Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med. 1998;338(19):1352\u20137.","journal-title":"N Engl J Med"},{"issue":"4","key":"2398_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0305-0491(93)90031-Y","volume":"106","author":"RC Hudson","year":"1993","unstructured":"Hudson RC, Daniel RM. l-Glutamate dehydrogenases: distribution, properties and mechanism. Comp Biochem Physiol B. 1993;106(4):767\u201392.","journal-title":"Comp Biochem Physiol B"},{"issue":"1","key":"2398_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11064-016-1986-x","volume":"42","author":"C Spanaki","year":"2017","unstructured":"Spanaki C, Kotzamani D, Plaitakis A. Widening spectrum of cellular and subcellular expression of human GLUD1 and GLUD2 glutamate dehydrogenases suggests novel functions. Neurochem Res. 2017;42(1):92\u2013107.","journal-title":"Neurochem Res"},{"issue":"12","key":"2398_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1469-8749.2008.03114.x","volume":"50","author":"N Bahi-Buisson","year":"2008","unstructured":"Bahi-Buisson N, Roze E, Dionisi C, Escande F, Valayannopoulos V, Feillet F, et al. Neurological aspects of hyperinsulinism\u2013hyperammonaemia syndrome. Dev Med Child Neurol. 2008;50(12):945\u20139.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"2398_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jpeds.2004.10.040","volume":"146","author":"DM Raizen","year":"2005","unstructured":"Raizen DM, Brooks-Kayal A, Steinkrauss L, Tennekoon GI, Stanley CA, Kelly A. Central nervous system hyperexcitability associated with glutamate dehydrogenase gain of function mutations. J Pediatr. 2005;146(3):388\u201394.","journal-title":"J Pediatr"},{"issue":"4","key":"2398_CR7","first-page":"1782","volume":"86","author":"C MacMullen","year":"2001","unstructured":"MacMullen C, Fang J, Hsu BY, Kelly A, de Lonlay-Debeney P, Saudubray JM, et al. Hyperinsulinism\/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase. J Clin Endocrinol Metab. 2001;86(4):1782\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"2398_CR8","first-page":"2802540","volume":"2018","author":"C Su","year":"2018","unstructured":"Su C, Liang XJ, Li WJ, Wu D, Liu M, Cao BY, et al. Clinical and molecular spectrum of glutamate dehydrogenase gene defects in 26 Chinese congenital hyperinsulinemia patients. J Diabetes Res. 2018;2018:2802540.","journal-title":"J Diabetes Res"},{"issue":"10","key":"2398_CR9","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/nbm.2949","volume":"26","author":"K Cai","year":"2013","unstructured":"Cai K, Singh A, Roalf DR, Nanga RP, Haris M, Hariharan H, et al. Mapping glutamate in subcortical brain structures using high-resolution GluCEST MRI. NMR Biomed. 2013;26(10):1278\u201384.","journal-title":"NMR Biomed"},{"issue":"309","key":"2398_CR10","doi-asserted-by":"publisher","first-page":"309ra161","DOI":"10.1126\/scitranslmed.aaa7095","volume":"7","author":"KA Davis","year":"2015","unstructured":"Davis KA, Nanga RP, Das S, Chen SH, Hadar PN, Pollard JR, et al. Glutamate imaging (GluCEST) lateralizes epileptic foci in nonlesional temporal lobe epilepsy. Sci Transl Med. 2015;7(309):309ra161.","journal-title":"Sci Transl Med."},{"issue":"9","key":"2398_CR11","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/mp.2016.258","volume":"22","author":"DR Roalf","year":"2017","unstructured":"Roalf DR, Nanga RPR, Rupert PE, Hariharan H, Quarmley M, Calkins ME, et al. Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum. Mol Psychiatry. 2017;22(9):1298\u2013305.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"2398_CR12","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/mrm.27362","volume":"80","author":"RPR Nanga","year":"2018","unstructured":"Nanga RPR, DeBrosse C, Kumar D, Roalf D, McGeehan B, D\u2019Aquilla K, et al. Reproducibility of 2D GluCEST in healthy human volunteers at 7 T. Magn Reson Med. 2018;80(5):2033\u20139.","journal-title":"Magn Reson Med"},{"key":"2398_CR13","volume-title":"Adaptive behavior assessment system, third edition (ABAS-3)","author":"P Harrison","year":"2015","unstructured":"Harrison P, Oakland T. Adaptive behavior assessment system, third edition (ABAS-3). London: Pearson Education Inc.; 2015."},{"key":"2398_CR14","volume-title":"The Achenbach system of empirically based assessment (ASEBA): development, findings, theory, and applications","author":"TM Achenbach","year":"2009","unstructured":"Achenbach TM. The Achenbach system of empirically based assessment (ASEBA): development, findings, theory, and applications. Burlington: University of Vermont Research Center for Children, Youth, & Families; 2009."},{"key":"2398_CR15","volume-title":"Behavior rating inventory of executive function-second edition (BRIEF2)","author":"GA Gioia","year":"2015","unstructured":"Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior rating inventory of executive function-second edition (BRIEF2). Lutz: Psychological Assessment Resources, Inc.; 2015."},{"key":"2398_CR16","volume-title":"Behavior rating inventory of executive function-adult version (BRIEF-A)","author":"RM Roth","year":"2005","unstructured":"Roth RM, Gioia GA. Behavior rating inventory of executive function-adult version (BRIEF-A). Lutz: Psychological Assessment Resources, Inc.; 2005."},{"issue":"3","key":"2398_CR17","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31(3):1116\u201328.","journal-title":"Neuroimage"},{"issue":"5","key":"2398_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1530\/EJE-09-0615","volume":"161","author":"RR Kapoor","year":"2009","unstructured":"Kapoor RR, Flanagan SE, Fulton P, Chakrapani A, Chadefaux B, Ben-Omran T, et al. Hyperinsulinism\u2013hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype\u2013phenotype correlations. Eur J Endocrinol. 2009;161(5):731\u20135.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2398_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1203\/00006450-200109000-00010","volume":"50","author":"P De Lonlay","year":"2001","unstructured":"De Lonlay P, Benelli C, Fouque F, Ganguly A, Aral B, Dionisi-Vici C, et al. Hyperinsulinism and hyperammonemia syndrome: report of twelve unrelated patients. Pediatr Res. 2001;50(3):353\u20137.","journal-title":"Pediatr Res"},{"issue":"7","key":"2398_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.seizure.2008.01.005","volume":"17","author":"N Bahi-Buisson","year":"2008","unstructured":"Bahi-Buisson N, El Sabbagh S, Soufflet C, Escande F, Boddaert N, Valayannopoulos V, et al. Myoclonic absence epilepsy with photosensitivity and a gain of function mutation in glutamate dehydrogenase. Seizure. 2008;17(7):658\u201364.","journal-title":"Seizure"},{"issue":"2","key":"2398_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pediatrneurol.2012.04.019","volume":"47","author":"K Nakano","year":"2012","unstructured":"Nakano K, Kobayashi K, Okano Y, Aso K, Ohtsuka Y. Intractable absence seizures in hyperinsulinism\u2013hyperammonemia syndrome. Pediatr Neurol. 2012;47(2):119\u201322.","journal-title":"Pediatr Neurol"},{"issue":"4","key":"2398_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nrl.2010.09.024","volume":"26","author":"F Perez Errazquin","year":"2011","unstructured":"Perez Errazquin F, Sempere Fernandez J, Garcia Martin G, Chamorro Munoz MI, Romero AM. Hyperinsulinism and hyperammonaemia syndrome and severe myoclonic epilepsy of infancy. Neurologia. 2011;26(4):248\u201352.","journal-title":"Neurologia"},{"issue":"44","key":"2398_CR23","doi-asserted-by":"publisher","first-page":"13929","DOI":"10.1523\/JNEUROSCI.4413-09.2009","volume":"29","author":"X Bao","year":"2009","unstructured":"Bao X, Pal R, Hascup KN, Wang Y, Wang WT, Xu W, et al. Transgenic expression of Glud1 (glutamate dehydrogenase 1) in neurons: in vivo model of enhanced glutamate release, altered synaptic plasticity, and selective neuronal vulnerability. J Neurosci. 2009;29(44):13929\u201344.","journal-title":"J Neurosci"},{"issue":"2","key":"2398_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nm.2615","volume":"18","author":"K Cai","year":"2012","unstructured":"Cai K, Haris M, Singh A, Kogan F, Greenberg JH, Hariharan H, et al. Magnetic resonance imaging of glutamate. Nat Med. 2012;18(2):302\u20136.","journal-title":"Nat Med"},{"issue":"9","key":"2398_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1515\/jpem-2016-0086","volume":"29","author":"D Ninkovic","year":"2016","unstructured":"Ninkovic D, Sarnavka V, Basnec A, Cuk M, Ramadza DP, Fumic K, et al. Hyperinsulinism\u2013hyperammonemia syndrome: a de novo mutation of the GLUD1 gene in twins and a review of the literature. J Pediatr Endocrinol Metab. 2016;29(9):1083\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"2398_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s11064-013-1235-5","volume":"39","author":"C Spanaki","year":"2014","unstructured":"Spanaki C, Kotzamani D, Petraki Z, Drakos E, Plaitakis A. Heterogeneous cellular distribution of glutamate dehydrogenase in brain and in non-neural tissues. Neurochem Res. 2014;39(3):500\u201315.","journal-title":"Neurochem Res"},{"key":"2398_CR27","unstructured":"Human Protein Atlas. Available from http:\/\/www.proteinatlas.org."},{"issue":"6220","key":"2398_CR28","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.","journal-title":"Science"}],"updated-by":[{"DOI":"10.1186\/s13023-022-02466-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000}}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02398-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T04:04:16Z","timestamp":1660795456000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02398-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,25]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2398"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02398-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,25]]},"assertion":[{"value":"5 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13023-022-02466-8","URL":"https:\/\/doi.org\/10.1186\/s13023-022-02466-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by the Institutional Review Board at Children\u2019s Hospital of Philadelphia. Written informed consent was obtained from participants or their parent\/legal guardian to participate in the study. In addition, written assent was obtained from participants\u2009<\u200918\u00a0years of age.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from participants or their parent\/legal guardian.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R.R. holds the patent (US 20120019245 A1) on CEST MRI methods for imaging metabolites and the use of same as biomarkers. D.D.D.L. has received research funding from Zealand Pharma, Tiburio Therapeutics, Twist Pharma, and Crinetics Pharmaceuticals for studies not included in this manuscript. D.D.D.L. has received consulting fees from Zealand Pharma, Crinetics Pharmaceuticals, Hanmi Pharmaceutical, Poxel SA, and Heptares Therapeutics not related to this manuscript. The other authors do not have any relevant disclosures to declare. The funding agencies did not have any role in study design, collection, analysis, and interpretation of data; or writing of the report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}